Aurora Cannabis (ACB)’ wholly owned subsidiary, MedReleaf Australia, has entered into a distribution partnership with Leafio, the wholesale distribution arm of Montu Australia. This strategic partnership will expand patient access to medical cannabis across Australia, while supporting healthcare professionals with educational resources. Leafio will serve as a wholesaler of Aurora’s leading portfolio of medical cannabis products under the MedReleaf, CraftPlant, Aurora, Whistler Cannabis Co. and IndiMed brands. Under the agreement, Aurora’s medical cannabis products will be distributed through Leafio’s nationwide supply chain, which services over 4,000 pharmacies.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACB:
- TLRY, CGC, CRON: Cannabis Stocks Jump as U.S. Medicare Considers Coverage
- Aurora Cannabis Reports Strong Q2 2026 Results
- Aurora Cannabis Earnings Call: Record Growth Amid Challenges
- Aurora Cannabis Reports Increased Revenue in Latest Financial Release
- Aurora Cannabis Achieves Record Revenue in Q2 2026